跳至主要内容
临床试验/NCT04680039
NCT04680039已完成不适用

Noninvasive Hemodynamic Parameters Measurements as a Tool for Early Warning of Intradialytic Hypotension in Hemodialysis Patients

Biobeat Technologies Ltd.1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2021年1月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
Number of participants with intradialytic hypotension

研究概览

简要总结

In this study, the investigators will monitor patients undergoing hemodialysis treatment with a non-invasive wearable PPG-based device. Measurements will include blood pressure, heart rate, oxygen saturation, stroke volume, cardiac output, cardiac index and systemic vascular resistance, among others. The aim is to diagnose intradialytic hypotension more rapidly than with current noninvasive methods and prevent related poor outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with EKSD undergoing chronic hemodialysis treatments for > 3 months.
  • Patients must be able to adhere to the visit schedule and protocol requirements and be available to complete the study.
  • Patients must satisfy a medical examiner about their fitness to participate in the study.
  • Patients must provide written informed consent to participate in the study.

排除标准

  • Patients with an inability to communicate well with the Principal investigator (PI) and staff (i.e., language problem, poor mental development, or impaired cerebral function).
  • Withholding the dialysis session for any reason prior to initiation.
  • Minors under the age of 18.

结局指标

主要结局

Number of participants with intradialytic hypotension

时间窗: Through study completion, an average of 1 year.

Using a PPG-based non-invasive wearable monitor to allow early detection of intradialytic hypotension

次要结局

  • Determining the pathogenesis of intradialytic hypotension(Through study completion, an average of 1 year.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验